Tectonic Therapeutic (TECX) Current Leases (2022 - 2026)
Tectonic Therapeutic (TECX) reported Current Leases of $1.2 million for Q1 2026, up 145.47% year-over-year from $475000.0 in Q1 2025, and up 238.95% quarter-over-quarter from $344000.0 in Q4 2025.
Tectonic Therapeutic (TECX) Current Leases (2022 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 5 years of Current Leases data on file, last reported at $1.2 million in Q1 2026.
- Current Leases for Q1 2026 came in at $1.2 million, up 145.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (up 145.47% YoY), and the FY2025 annual result was $344000.0, down 29.65% from the prior year.
- Current Leases improved to $1.2 million in Q1 2026 per TECX's latest filing, from $344000.0 in the prior quarter.
- Over five years, Current Leases peaked at $2.6 million in Q1 2023 and troughed at $224000.0 in Q1 2024.
- A 5-year average of $1.0 million and a median of $744000.0 in 2022 frame the typical range for Current Leases.
- The sharpest annual moves came in 2024 and 2026: Current Leases tumbled 91.47% in 2024, then surged 145.47% in 2026.
- A 5-year view of Current Leases shows it stood at $999000.0 in 2022, then plunged by 52.45% to $475000.0 in 2023, then grew by 2.95% to $489000.0 in 2024, then retreated by 29.65% to $344000.0 in 2025, then soared by 238.95% to $1.2 million in 2026.
- Business Quant data shows TECX's Current Leases at $1.2 million in Q1 2026, $344000.0 in Q4 2025, and $413000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | 1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.17 Mn |
| Dec 31, 2025 | 344,000.00 |
| Sep 30, 2025 | 413,000.00 |
| Jun 30, 2025 | 451,000.00 |
| Mar 31, 2025 | 475,000.00 |
| Dec 31, 2024 | 489,000.00 |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | 1.43 Mn |
| Mar 31, 2024 | 224,000.00 |
| Dec 31, 2023 | 475,000.00 |
| Sep 30, 2023 | 1.65 Mn |
| Jun 30, 2023 | 2.25 Mn |
| Mar 31, 2023 | 2.63 Mn |
| Dec 31, 2022 | 999,000.00 |